108 related articles for article (PubMed ID: 11062220)
1. In vitro activity of beta-lactams against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Carricajo A; Fonsale N; Vautrin AC; Aubert G
J Antimicrob Chemother; 2000 Nov; 46(5):856-8. PubMed ID: 11062220
[No Abstract] [Full Text] [Related]
2. Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.
Snydman DR; McDermott LA; Jacobus NV
J Chemother; 2005 Dec; 17(6):614-21. PubMed ID: 16433191
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefpirome and vancomycin in combination against gentamicin-susceptible and gentamicin-resistant Staphylococcus aureus.
Carricajo A; Vermesch R; Aubert G
Clin Microbiol Infect; 2001 Apr; 7(4):218-26. PubMed ID: 11422245
[No Abstract] [Full Text] [Related]
4. [Characteristics of gentamicin-resistant strains of Staphylococcus aureus isolated from diagnostic specimens].
Gołuszko P; Grabowska A; Gospodarek E; Bugalski R; Marciniak M
Przegl Epidemiol; 1984; 38(4):435-40. PubMed ID: 6533685
[No Abstract] [Full Text] [Related]
5. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Chandrasekar PH; Sluchak JA
Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600
[TBL] [Abstract][Full Text] [Related]
6. Gentamicin-resistant Staphylococcus aureus strains and their susceptibility to other aminoglycosides.
Bang J; Rosdahl VT; Bentzon MW; Rosendal K
Acta Pathol Microbiol Immunol Scand B; 1982 Oct; 90(5):361-70. PubMed ID: 7148459
[No Abstract] [Full Text] [Related]
7. Bactericidal activity of Sch 34343 alone and in combination with gentamicin.
Shah PM; Schneider K; Stille W
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():165-71. PubMed ID: 3897171
[TBL] [Abstract][Full Text] [Related]
8. [New plasmid resistance of Staphylococcus aureus to aminosides (gentamicin, tobramycin, amikacin].
Soussy CJ; Dublanchet A; Cormier M; Bismuth R; Mizon F; Chardon H; Duval J; Fabiani G
Nouv Presse Med; 1976 Nov; 5(39):2599-602. PubMed ID: 995590
[TBL] [Abstract][Full Text] [Related]
9. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
[TBL] [Abstract][Full Text] [Related]
10. Testing Staphylococcus aureus for resistance to beta-lactams.
Goldstein FW; Acar J
J Antimicrob Chemother; 1991 Apr; 27(4):549-50. PubMed ID: 1953884
[No Abstract] [Full Text] [Related]
11. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin.
Aritaka N; Hanaki H; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2001 Apr; 45(4):1292-4. PubMed ID: 11257050
[TBL] [Abstract][Full Text] [Related]
12. Gentamicin resistance in Staphylococcus aureus.
Porthouse A; Brown DF; Smith RG; Rogers T
Lancet; 1976 Jan; 1(7949):20-1. PubMed ID: 54520
[TBL] [Abstract][Full Text] [Related]
13. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
[TBL] [Abstract][Full Text] [Related]
14. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
McConeghy KW; LaPlante KL
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
[TBL] [Abstract][Full Text] [Related]
16. Gentamicin-susceptible or gentamicin-resistant methicillin-resistant Staphylococcus aureus: a case-case study.
Robert J; Bismuth R; Lemaitre N; Jarlier V
Infect Control Hosp Epidemiol; 2006 Aug; 27(8):879-83. PubMed ID: 16874652
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
Melby K; Midtvedt T; Dahl O
Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of five antibiotics against methicillin and gentamicin resistant Staphylococcus aureus.
Jamal F; Abd Aziz HB; Jais MR
Malays J Pathol; 1985 Aug; 7():41-3. PubMed ID: 3855178
[No Abstract] [Full Text] [Related]
20. [Evolution of antibiotic-resistance Staphylococcus aureus in Saint Camille Medical Centre in Ouagadougou].
Karou SD; Nadembega MC; Zeba B; Ilboudo DP; Ouermi D; Pignatelli S; Pietra V; Gbeassor M; De Souza C; Simpore J
Med Trop (Mars); 2010 Jun; 70(3):241-4. PubMed ID: 20734590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
